Speakers

Judd W. Moul, MD

Director, Duke Prostate Center

Duke University Medical Center

Dr Judd W. Moul is Professor and Chief of the Division of Urologic Surgery and Director of the Duke Prostate Center at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland and an attending Urologic Oncologist at the Walter Reed Army Medical Center (WRAMC) in Washington, DC. In addition, he was Director of the Center for Prostate Disease Research (CPDR); a Congress mandated research program of the Department of Defense based at USUHS and WRAMC. Dr Moul completed his Urologic Oncology Fellowship at Duke University and graduated Summa Cum Laude from Pennsylvania State University. He earned his medical degree from Jefferson Medical College. Dr Moul currently serves on the editorial boards of Urology, Brazilian Journal of Urology and World Journal of Robotic Surgery, and is Co-Editor of Prostate Cancer and Prostatic Diseases. He has published over 500 medical and scientific manuscripts and book chapters and has lectured at national and international meetings. Honors received have included the 1995 American Medical Association Young Physicians Section Community Service Award for his national involvement in prostate cancer patient support groups, the 1996 Sir Henry Welcome Research Medal and Prize from the Association of Military Surgeons of the United States, and selection as a 1994 Fellow for the American Urological Association/European Association of Urology International Academic Exchange Program. In 2006, Dr. Moul was selected as Chairman of the newly founded American Urological Association Foundation Education Council.

New Directions in the Management of mCRPC


Anthony Schaeffer, MD

Chairman, Department of Urology

Northwestern University Feinberg School of Medicine

Dr. Schaeffer has been Professor and Chairman of the Department of Urology at Northwestern University since 1990. He is best known for his pioneering work in basic and clinical research on urinary tract infections and prostatitis which involves novel concepts for the cause and treatment of these conditions. He has also made major contributions to management of post-prostatectomy incontinence through implementation of a bulbo-urethral sling procedure. Along with colleagues, he was the first to describe the systemic changes in the mucosal adhesive characteristics that increase the ability of pathogenic bacteria to bind to the mucosa and subsequently cause urinary tract infections in women; to develop a self-start technique for patient-based management of urinary tract infections; to demonstrate that pathogenic bacteria modify expression of their adhesive characteristics in vitro and in vivo; and to determine that an immunoglobulin (secretory IgA) present in vaginal fluid modifies susceptibility to urinary tract infections. For these and other accomplishments he was awarded a National Institutes of Health Merit Award Grant to continue research on urinary tract infections. He is currently Chair of the National Institutes of Health Multi-Site Collaborative Research Project on male chronic pelvic pain syndrome (prostatitis) and contributes regularly to international panels to establish guidelines for management of urinary tract infections.

Beyond the PSA: Emerging Biomarkers for Prostate Cancer Screening









John L. Marshall, MD

Professor and Chief, Division of Hematology/Oncology

Georgetown University Hospital



Patrick F. Fogarty, MD

Director, Penn Comprehensive Hemophilia and Thrombosis Program

Hospital of the University of Pennsylvania

Patrick F. Fogarty, MD, is Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, Pennsylvania and Director of the Penn Comprehensive Hemophilia and Thrombosis Program, Hospital of the University of Pennsylvania. After earning his medical degree from Jefferson Medical College, Philadelphia, Pennsylvania, Dr. Fogarty completed his residency in Internal Medicine at Georgetown University Medical Center in Washington, DC. He then went on to complete a fellowship in Hematology/Oncology and a clinical research fellowship in Hemostasis and Thrombosis at the National Heart, Lung, and Blood Institute of the National Institutes of Health, in Bethesda, Maryland. He then was appointed Director of the Adult Hemophilia Program and Co-Director of the UCSF Comprehensive Hemophilia Treatment Center, University of California, San Francisco, where he was an Associate Professor of Clinical Medicine in the Division of Hematology/Oncology. Dr. Fogarty is board-certified in hematology and medical oncology. He is a member of the Hemostasis and Thrombosis Research Society, the American Society of Hematology, the International Society on Haemostasis and Thrombosis, the National Hemophilia Foundation, and the World Federation of Haemophilia. He maintains an active program in clinical research in hemostasis and thrombosis; recent investigations have included validation of bleeding scores and epidemiologic assessments of co-morbidities affecting inherited and acquired disorders of hemostasis. He is a panel member and author of the National Comprehensive Cancer Network’s Guideline for Supportive Care, Venous Thromboembolic Disease. He is a member of the Steering Committee for U.S. pilot studies in hemophilia. Dr. Fogarty serves as a reviewer for numerous peer-reviewed journals. He is frequently invited to speak at national and international meetings on disorders of hemostasis and thrombosis, and has contributed to/edited multiple reference volumes on bleeding and clotting conditions.

Therapeutic Advances in the Management of Hemophilia






Forgot Password Click Here to Register